Table 2:

3T ADC values in malignant neck lesions

Age, y/SexLesionStageADC, × 10−3 mm2/s
65/MSinonasal undifferentiated SCC (P)T4N0M00.719 ± 0.157
35/MSinonasal undifferentiated SCC (P)T4N0M01.042 ± 0.068
51/FSCC Parotid (P)T4N2M11.064 ± 0.162
61/MSCC palatine tonsil (P)T4N2BM00.847 ± 0.083
62/MSCC palatine tonsil (P)T4N3M10.733 + 0.055
62/MSCC palatine tonsil (MD)T3N1M01.261 ± 0.168
59/MSCC base of tongue (P)T2N3M00.955 ± 0.095
65/FSCC soft palate (P)T1N3M01.033 ± 0.183
78/FSCC nasopharynx (W)T4N0M01.319 ± 0.194
58/MSCC supraglottis (MD)T4N2BM01.278 + 0.070
83/MSCC supraglottis (MD)T4N0M01.138 ± 0.148
43/MSCC oropharynx (MD)T4N1M01.359 + 0.087
90/FSCC orbit (W)T4N1M11.055 ± 0.047
40/FAdenosquamous cell carcinoma skull baseT4N0M01.649 ± 0.229
57/FCarcinoma ex pleomorphic adenoma (parotid)T2N1M01.241 ± 0.194
69/MOrbital B-cell lymphoma3A0.438 ± 0.099
  • Note:—SCC indicates squamous cell carcinoma; W, well-differentiated; MD, moderately differentiated; P, poorly differentiated; F, female; M, male; ADC, apparent diffusion coefficient.